Shin Nippon Biomedical Laboratories, Ltd.
Symbool: 2395.T
JPX
1392
JPYMarktprijs vandaag
10.3343
Koers/Winst Verhouding
-0.0844
Koers/Winst Groei Verhouding
57.95B
MRK Kapitalisatie
- 0.04%
DIV Rendement
Shin Nippon Biomedical Laboratories, Ltd. (2395-T) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 10533.1 | 6997 | 7286.5 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | -423.6 | 368.1 | 55.8 | |||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 4760.4 | 3501.6 | 2954.1 | |||||||||||||||||||
balance-sheet.row.inventory | 0 | 7329.4 | 4359.4 | 4071.4 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 1276.7 | 1276.5 | 468.1 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 23899.6 | 16134.5 | 14780 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 18879.3 | 13155.8 | 12898 | |||||||||||||||||||
balance-sheet.row.goodwill | 0 | 1438.8 | 0.3 | 0.8 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 260.7 | 212 | 213 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1699.4 | 212.3 | 213.8 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 12404 | 8645 | 8522 | |||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 325.8 | 1129.6 | 521.6 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 34.2 | 35.4 | 37 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 33342.6 | 23178.2 | 22192.4 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-assets | 0 | 57242.2 | 39312.7 | 36972.4 | |||||||||||||||||||
balance-sheet.row.account-payables | 0 | 419.8 | 64.6 | 95 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 8923.2 | 2942.7 | 3486.8 | |||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 603.7 | 743.1 | 683.2 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 9837.5 | 6195.6 | 9199.2 | |||||||||||||||||||
Deferred Revenue Non Current | 0 | -1064 | -68.2 | -642.4 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 3009.8 | 2685.1 | 2317.4 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 9871.5 | 6215.6 | 9217.8 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 357 | 385.8 | 529.3 | |||||||||||||||||||
balance-sheet.row.total-liab | 0 | 30883.2 | 19589.5 | 21133.6 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 2620.8 | 105.7 | |||||||||||||||||||
balance-sheet.row.common-stock | 0 | 9679.1 | 9679.1 | 9679.1 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 13766.2 | 10196.3 | 3854.5 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 460.2 | -2620.8 | -105.7 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2306.4 | -314.3 | 2200.9 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 26211.8 | 19561.1 | 15734.5 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 57242.2 | 39312.7 | 36972.4 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 147.2 | 162 | 104.3 | |||||||||||||||||||
balance-sheet.row.total-equity | 0 | 26359 | 19723.1 | 15838.8 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||
Total Investments | 0 | 11980.4 | 7080.1 | 8286.9 | |||||||||||||||||||
balance-sheet.row.total-debt | 0 | 18760.7 | 9138.3 | 12686.1 | |||||||||||||||||||
balance-sheet.row.net-debt | 0 | 8227.6 | 2509.4 | 5455.3 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 7759.6 | 8183.3 | 4175.6 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1600.5 | 1177.4 | 1187.7 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -2812.9 | 723.3 | 532 | |||||||||||||||||||
cash-flows.row.account-receivables | 0 | -937 | -480 | -343 | |||||||||||||||||||
cash-flows.row.inventory | 0 | -968.5 | -371.1 | -71.7 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | -268.2 | -36.7 | -24.2 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -639.2 | 1611.1 | 970.8 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -2543.2 | -4131.3 | -1148.5 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -4955.7 | -1614.3 | -1118 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -1937.2 | 1200.8 | 1242.3 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -1514.3 | -4194.1 | -895 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 2532.2 | 266.7 | 91.4 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -55.5 | 72.3 | 410.6 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -5930.6 | -4268.5 | -268.7 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -5468.1 | -3492.3 | -4598.2 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0.2 | 0 | 0 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -0.2 | 0 | 0 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2484.4 | -826.5 | -206.2 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 14218.8 | -593.1 | 2333.4 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 6266.2 | -4912 | -2471.1 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 311.5 | 496.7 | 29.6 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 4648.9 | -2731 | 2036.6 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 9197.7 | 4548.8 | 7279.8 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 4548.8 | 7279.8 | 5243.3 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 4004 | 5952.8 | 4746.7 | |||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -4955.7 | -1614.3 | -1118 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -951.7 | 4338.5 | 3628.7 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 25090.9 | 17748.5 | 15110.5 | |||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 12044.2 | 8061.2 | 7556.1 | |||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 13046.7 | 9687.3 | 7554.4 | |||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 15.2 | 191.1 | 211.4 | |||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 7801.4 | 5491.7 | 5024.9 | |||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 19845.7 | 13552.9 | 12581 | |||||||||||||||||||
income-statement-row.row.interest-income | 0 | 57.4 | 8.3 | 3 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 125.1 | 126.6 | 184.9 | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 2514 | 3986 | 1644 | |||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 15.2 | 191.1 | 211.4 | |||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 2514 | 3986 | 1644 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 125.1 | 126.6 | 184.9 | |||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1600.5 | 1177.4 | 1187.7 | |||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.operating-income | 0 | 5245.2 | 4195.6 | 2529.5 | |||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 7759.6 | 8183.3 | 4175.6 | |||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 1708.9 | 1016.2 | 497.8 | |||||||||||||||||||
income-statement-row.row.net-income | 0 | 6060.1 | 7127.6 | 3661.9 |
Vaak gestelde vragen
Wat is Shin Nippon Biomedical Laboratories, Ltd. (2395.T) totale activa?
Shin Nippon Biomedical Laboratories, Ltd. (2395.T) totale activa is 57242205000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.522.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.206.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.150.
Wat is Shin Nippon Biomedical Laboratories, Ltd. (2395.T) nettowinst (netto-inkomen)?
De nettowinst is 6060057000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 18760662000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 7801426000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.